TMX-049

N/A

Report date: 2024/06/04 20:00:06
NME

Base Information

Drug NameTMX-049
Drug Alias NameTMX-049TMX-049DN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXortx TherapeuticsTeijin America Inc
Active IndicationsN/A
Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A